|
|
|
By Jeffrey S. Buguliskis, Ph.D., Deputy Chief Editor, Outsourced Pharma | Capacity isn’t the choke point—capability is; this piece ranks nine fast-growing outsourcing segments and shows sponsors how to win by locking in modality-proven partners early. | |
|
|
| Redefining CAR-T Speed And Strength: A Conversation | Q&A | Resilience US, Inc. | Discover how an autologous CAR-T platform is addressing challenges in cell therapy manufacturing. A three-day process shortens cycles, improves T-cell potency and durability, and reduces costs. |
|
|
| Unravelling The Complexities Of ADC Manufacturing | White Paper | Pfizer CentreOne | Whether you're in the early stages of development or scaling up for commercialization, understanding ADC manufacturing challenges is essential for bringing life-saving therapies to patients worldwide. |
|
|
| Protein Stress Testing | White Paper | Labcorp Biopharmaceutical CMC Services | Start your forced degradation studies early to uncover molecular risks, strengthen product stability, and ensure regulatory-ready development from the start. |
|
|
| Application Of Plant And Process Models | White Paper | Boehringer Ingelheim Biopharmaceuticals GmbH | Explore innovative process and facility models that optimize efficiency, sustainability, and cost-effectiveness in biopharmaceutical manufacturing. |
|
|
| Does Your CDMO Have An Analytical Edge? | Article | By Anna Małecka and Paulina Toboła, Mabion | Due to the complexity of biologics, precise analytical technology is crucial throughout every phase of drug development to ensure the highest standards of quality, safety, and regulatory compliance. |
|
|
|
|
|
| Cytokines For Ex Vivo Cell Culture | Application Note | By Janet J. Sei, Rahul Purohit, Samatha Bandapalle, et al., Lonza | Comparable T cell expansion and function between cytokine sources were demonstrated. Generated CAR-T cells showed robust cytotoxicity and lower exhaustion markers. |
|
|
| BD Vystra Disposable Pen | Infographic | BD Medical - Pharmaceutical Systems | BD Vystra Disposable Pen is a proven, globally adopted drug delivery platform with over 175 million units sold, supporting diverse therapies in 40+ countries. |
|
|
| How To Choose The Right CDMO Partner For Fill & Finish | Article | medac CDMO | CDMO selection requires evaluating experience, quality standards, and flexibility. Assess technical transfer skills, supply chain security, and collaborative approach for a reliable, long-term project fit. |
|
|
|
|
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|